Avecia
Avecia was a privately owned group of biotechnology companies with recognised leading positions in process development and manufacture of biological and oligonucleotide pharmaceuticals, and had their international headquarters in Blackley, Manchester, England.
The group's Biologics business, based in Billingham UK, was acquired first by Merck and then subsequently became Fujifilm Diosynth Biotechnologies in April 2011. The group's OligoMedicines business was acquired by Nitto Denko in February 2011, and so the Avecia Group no longer exists as a trading company. The trading name is now used by Nitto Denko Avecia Inc.